KIM, NORMAN, N.,MCVICAR, WILLIAM, K.,MCCAULEY, THOMAS,BAUMGARTNER, RUDOLF, A.
申请号：
SG2012047882
公开号：
SG182285A1
申请日:
2011.01.11
申请国别(地区):
SG
年份:
2012
代理人:
摘要：
The present invention is directed to a combination or a kit comprising a prostaglandin analog and an adenosine receptor A1 agonist and to a method of reducing intraocular pressure (IOP) in a subject using such combination or kit. The invention is particularly directed to a combination of latanoprost marketed under the brand Xalatan TM and Compound A.
